Palace: We’ll run after Pharmally if... | Inquirer News

Palace: We’ll run after Pharmally if…

/ 05:32 AM October 30, 2021

MANILA, Philippines — Malacañang said on Friday that it would run after executives of Pharmally Pharmaceutical Corp., which bagged multibillion-peso contracts to supply the government with pandemic equipment, if they have not been paying proper taxes.

“The executive (branch of government) will lead the collection of taxes, if these need to be collected because we need funds during the pandemic. Do not worry, the [Bureau of Internal Revenue] is not sleeping on the job. If there are deficiencies in tax payments, we will run after it, and that is guaranteed,” presidential spokesperson Harry Roque said in a press briefing.

Senators have surmised that Pharmally and its executives might not have paid the proper amount of taxes after bagging P11.5 billion in government contracts in 2020 and 2021.

Article continues after this advertisement

Roque also downplayed the claim of Sen. Risa Hontiveros that President Rodrigo Duterte had a special relationship with Wang Min, chair of Xuzhou Construction Machinery Group (XCMG), another company under Senate investigation.

Hontiveros presented a picture showing the President with Wang and described XCMG, which bagged P2.23 billion worth of contracts with the government, as a “tax evader” and was not even registered with the Bureau of Customs and Securities and Exchange Commission.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: BIR, Pharmally, Rodrigo Duterte, Tax, Wang Min

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.